Tag: MTC HEA BIO

Epigenetics Market worth US$4.29 billion in 2030 with 13.9% CAGR | MarketsandMarkets™

DELRAY BEACH, Fla., Aug. 15, 2025 /PRNewswire/ -- The global Epigenetics Market, valued at US$2.03 billion in 2024, stood at US$2.24 billion in 2025...

KBP’s Contest of Injunction Obtained by Novo Nordisk Continues in Arbitration

SINGAPORE, Aug. 13, 2025 /PRNewswire/ -- KBP Biosciences Pte. Ltd. (the "Company") today issued a statement addressing a further decision by the Singapore International...

Sobi publishes Q2 2025 report: Continued strong portfolio and pipeline momentum

STOCKHOLM, July 16, 2025 /PRNewswire/ -- Swedish Orphan Biovitrum AB (publ) (Sobi®) today announced its report for the second quarter 2025 Second Quarter 2025 Total revenue increased 13...

Sobi publishes Q2 2025 report: Continued strong portfolio and pipeline momentum

STOCKHOLM, July 16, 2025 /PRNewswire/ -- Swedish Orphan Biovitrum AB (publ) (Sobi®) today announced its report for the second quarter 2025 Second Quarter 2025 Total revenue increased 13...

MGI Tech Partners with Asia Pathogen Genomics Initiative to Advance Pathogen Genomics for Public Health in Asia

SINGAPORE, June 11, 2025 /PRNewswire/ -- MGI Tech Co., Ltd. ("MGI"), a company dedicated to developing core tools and technologies that drive innovation in...

Job Satisfaction Under Pressure: Survey of 528 Life Science Professionals Reveals Impact of Budget Cuts, Workload Increases, and Career Uncertainty

ARLINGTON, Va., June 6, 2025 /PRNewswire/ -- BioInformatics, a Science and Medicine Group company, has released the latest edition of its free monthly Beyond the...

- A word from our sponsors -

Newsletter Signup

Name(Required)

First Last

Email(Required)

Enter Email Confirm Email

CAPTCHA

Privacy(Required)

I agree with the storage and handling of my data by this website. - Privacy Policy *

This field is for validation purposes and should be left unchanged.

HomeTagsMTC HEA BIO

Antag Therapeutics presents positive Phase 1 results at the 2026 Scientific Sessions of the American Diabetes Association for AT7687, a first-in-class GIPR antagonist

CREDIT AGRICOLE S.A. ANNOUNCES REDEMPTION OF ¥84,200,000,000 Japanese Yen Callable Senior Non-Preferred Bonds issued on June 3, 2021 (ISIN: JP525022AM69)

ROSEN, SKILLED INVESTOR COUNSEL, Encourages Veritone, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – VERI

Tag: MTC HEA BIO

Epigenetics Market worth US$4.29 billion in 2030 with 13.9% CAGR | MarketsandMarkets™

KBP’s Contest of Injunction Obtained by Novo Nordisk Continues in Arbitration

Sobi publishes Q2 2025 report: Continued strong portfolio and pipeline momentum

Sobi publishes Q2 2025 report: Continued strong portfolio and pipeline momentum

MGI Tech Partners with Asia Pathogen Genomics Initiative to Advance Pathogen Genomics for Public Health in Asia

Job Satisfaction Under Pressure: Survey of 528 Life Science Professionals Reveals Impact of Budget Cuts, Workload Increases, and Career Uncertainty

Newsletter Signup

Explore

Press Releases

News & Opinion

Living

Others

Follow us